Quantcast

Latest Rosiglitazone Stories

2013-08-19 23:24:57

The Corporate Whistleblower Center says, "The announcement on July 27th, 2013 that GlaxoSmithKline would pay a $229 million dollar fine to numerous states for a drug that had severe side effects is a very good reason for a drug industry insiders to call us at 866-714-6466, about potential whistleblower cases. The only proviso is the potential whistleblower must possess documentation about a defective drug, and/or hidden side effects, because the rewards can be so significant for this...

2013-08-06 23:17:37

The first major Actos lawsuit cases moving through the legal system offer hope to patients allegedly harmed by Actos use. LOS ANGELES (PRWEB) August 06, 2013 The national law firm of Baron and Budd is reviewing results of the first major Actos lawsuit cases alleging that patients had an increased risk of bladder cancer due to Actos use. A popular drug used to help control blood sugar levels, Actos has been on the market and trusted by patients and doctors alike as an effective diabetes...

2013-06-28 23:19:03

GranuFlo lawsuit involving patients who allegedly suffered heart attacks, cardiac arrest, stroke or sudden cardiac death while undergoing dialysis treatment with recalled NaturaLyte or GranuFlo dialysis drug, both Fresenius products, grows. Dallas, TX (PRWEB) June 28, 2013 A MDL Statistics Report issued on May 14th by the U.S. Judicial Panel on Multidistrict Litigation (JPML) claims that at least 161 Fresenius GranuFlo lawsuit cases have been filed in federal litigation in the district of...

2013-06-14 23:04:48

Alert: Diabetes Drug Actos Has Allegedly Been Linked to Serious Health Problems, Including Bladder Cancer DALLAS (PRWEB) June 14, 2013 National plaintiffs´ law firm Baron and Budd is now handling lawsuits regarding the alleged adverse side effects of the diabetes drug Actos. Actos, also known as pioglitazone, has been prescribed since 1999 to help treat type 2 diabetes. The drug was marketed to help people control blood sugar levels with a minimum of side effects, making it a...

2013-05-09 23:43:35

Alert: Granuflo Allegedly Linked to Serious Health Risks Including Stroke, Heart Attack and Cardiopulmonary Arrest. Dallas, TX (PRWEB) May 08, 2013 The National Plaintiff´s Law Firm of Baron and Budd is now handling lawsuits pertaining to the recall of Granuflo, the brand name of a dialysate (http://www.fda.gov/medicaldevices/safety/listofrecalls/ucm309990.htm ). Dialysate is used when a patient undergoes dialysis, a long-term medical treatment used to treat kidney conditions....

2013-04-23 22:38:17

Epoxide hydrolase inhibition and thiazolidinediones Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with tAUCB (trans-4-(4-[3-adamantan-1-yl-ureid]-cyclohexyloxy)-benzoic acid) and activating peroxisome proliferator-activator receptorγ (PPARγ) with the thiazolidinedione rosiglitazone on the...

2013-04-19 23:01:41

The Law Offices of Berman and Berman have just announced that they are taking new Avandia lawsuit and compensation cases. They have successfully worked many cases for the generic drug Rosiglitazone, which goes by the brand name Avandia. New York, NY (PRWEB) April 19, 2013 The Berman Law Group are extending their legal efforts in fighting for justice for all people who have been potentially hurt by the drug Avandia. They are now taking new cases and are able to fight and potentially win...

FDA Advisory Panel To Re-Evaluate Diabetes Drug Avandia In June
2013-04-14 07:29:51

redOrbit Staff & Wire Reports — Your Universe Online Three years after restricting sales of Avandia, the US Food and Drug Administration (FDA) has scheduled a health advisory panel to re-evaluate the safety of the diabetes drug, various media outlets reported on Friday. The FDA limited the availability of the pill to patients who could not control their diabetes with any other medication due to an increased risk of heart attack and death associated with the product, according...

2013-03-05 23:04:11

The law firm of d´Oliveira & Associates has issued a new infographic about the type-2 diabetes drug, Actos, and potential dangers the drug may pose. (PRWEB) March 05, 2013 Manufactured by the Japanese pharmaceutical company Takeda, Actos (pioglitazone) is a type-2 diabetes drug used to control glucose levels in patients over the age of 18 years. The FDA drug safety information on Actos lists possible side effects that include nausea, hypoglycemia, broken bones, eye problems, and...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related